Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2)

Medical Journal of Australia

Volumn 185, Issue 9, 2006, Pages 487-489

  Nelson, Mark R ^a   Reid, Christopher M ^b   Ryan, Philip ^c   Willson, Kristyn ^c   Yelland, Lisa ^c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; AUSTRALIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; DIASTOLIC BLOOD PRESSURE; DIURETIC THERAPY; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; QUESTIONNAIRE; RISK ASSESSMENT; SELF REPORT; TREATMENT RESPONSE;

EID: 33751070708     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2006.tb00662.x     Document Type: Article

References (13)

1. Haynes RB, Taylor DW, Sacket DL. Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.
2. Kanani R, McKibbon KA, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. http://www.cochrane.org/colloquia/ abstracts/hamilton/hamiltonP20.htm (accessed June 2006).
3. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002; 40: 794-811.
4. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
5. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74.
6. Wing LMH, Reid CM, Ryan F, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med2003; 348:583-592.
7. Wei J, Lin D, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989; 84: 1065-1073.
8. Li Q, Lagakos S. Use of the Wei-Lin-Weissfeld method for the analysis of a recurring and a terminating event. Stat Med 1997; 16: 925-940.
9. Svensson S, Kjellgren KI, Ahlner J, Saljo R. Reasons for adherence with antihypertensive medication. Int J Cardiol 2000; 76: 157-163.
10. Benson J, Britten N. Patients' decisions about whether or not to take anti hypertensive drugs: qualitative study. BMJ 2002; 325: 873-877.
11. Grégoire JP, Guibert R, Archambault A, Contandriopoulos AP. The measure of non-compliance to drug treatment. Comparison of pill counts and pharmacy records. J Soc Adm Pharm 1997; 14:198-207.
12. Krousel-Wood M, Muntner P, Jannu A, et al. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci 2005; 330:128-133.
13. Schoberberger R, Janda M, Pescosta W, Sonneck G. The COMpliance Praxis Survey (COMPASS): a multidimensional instrument to monitor compliance for patients on antihypertensive medication. J Hum Hypertens 2002; 16: 779-787.